Skip to content

Clinical trials

Phase 2 Hypertension trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypertension Phase: Phase 2 Country / region: France Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20041
20072
20081
20101
20121
20141
20171
20181
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
Institut de Recherches Internationales Servier2
Ablative Solutions, Inc.1
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA1
Bayer1
Novartis1
RECORDATI GROUP1
University Hospital, Grenoble1
University Hospital, Rouen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypertension13
Essential Hypertension2
Diabetes Mellitus1
Diabetes Mellitus, Type 21
Diabetic Nephropathies1
Hyperaldosteronism1
Hypertension, Pulmonary1
Hypokalemia1
Idiopathic Interstitial Pneumonias1
Kidney Diseases1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.